Provided by Tiger Fintech (Singapore) Pte. Ltd.

LAVA Therapeutics N.V.

1.32
+0.04003.13%
Volume:151.64K
Turnover:201.86K
Market Cap:34.71M
PE:-1.30
High:1.38
Open:1.30
Low:1.28
Close:1.28
Loading ...
Feb 28, 2025

Major Issues Report

Form 8-K - Current report
Feb 25, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Major Issues Report

Form 8-K - Current report
Mar 20, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 07, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 10, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 06, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 11, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 24, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 23, 2022

[Rev.]Annual Report

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Dec 12, 2022

Correspondence

CORRESP [Cover] - Correspondence
Oct 03, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 30, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 20, 2022

Correspondence

CORRESP [Cover] - Correspondence